Total hip arthroplasty: to cross-match or not to cross-match an evidence-based, cost-effective and safe protocol

被引:0
|
作者
Sivardeen, K. A. Ziali [1 ]
Kaleel, Sahadu Saajid [2 ]
Paul, Weaver [3 ]
Chandran, Prakash [3 ]
机构
[1] Royal Orthopaed Hosp, Dept Trauma & Orthopaed, Birmingham, W Midlands, England
[2] Luton & Dunstable Hosp, Dept Trauma & Orthopaed, Luton, Beds, England
[3] Alexandra Hosp, Blood Transfus Serv, Redditch B98 7UB, England
关键词
blood transfusion; total hip replacement;
D O I
10.1007/s00590-007-0268-3
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background and purpose Most centres cross-match between 2 and 4 units of blood pre-operatively for primary total hip arthroplasties (THA), but is this necessary? We aimed to quantify the use of blood after THA in our centre and to advocate a safe, evidence-based protocol for its use. Method A retrospective analysis of blood transfusion requirements of 169 consecutive total hip arthroplasties over a 12-month period. Results Out of the 460 units of blood that were cross-matched only 175 units (38%) were used. Only 22 of the 175 units (13%) were transfused on the day of surgery. No patients needed intra-operative transfusion or blood urgently. Inference We conclude that blood should not be routinely cross-matched for primary THA. We advocate a policy of only group and saving of blood in the majority of patients undergoing primary THA and cross matching blood if and when necessary. However, the 1-2% of patients who have antibodies present in the blood as per group and screen should have blood cross-matched and available pre-operatively. We believe this protocol, is safe and cost effective, resulting in a significant saving in cost, without compromising safety.
引用
收藏
页码:107 / 109
页数:3
相关论文
共 50 条
  • [31] THE PROS AND CONS OF ABBREVIATING THE MAJOR CROSS-MATCH
    SHULMAN, IA
    NELSON, JM
    JOURNAL OF MEDICAL TECHNOLOGY, 1986, 3 (07): : 417 - 419
  • [32] THE ANTIGLOBULIN CROSS-MATCH IN THE CYCLOSPORINE ERA - REPLY
    GIFFORD, RRM
    DORAN, MM
    RUTH, JA
    COPPAGE, ML
    WINSETT, OE
    FISH, JC
    TRANSPLANTATION, 1987, 44 (02) : 333 - 334
  • [33] Toolkit of automated database creation and cross-match
    Zhang, Yanxia
    Zheng, Hongwen
    Pei, Tong
    Zhao, Yongheng
    SOFTWARE AND CYBERINFRASTRUCTURE FOR ASTRONOMY II, 2012, 8451
  • [34] BLOOD CROSS-MATCH FOR CESAREAN-SECTION
    DAVIES, AO
    CANADIAN ANAESTHETISTS SOCIETY JOURNAL, 1981, 28 (05) : 491 - 492
  • [35] THE USE OF BROMELIN IN ESTABLISHING A STANDARD CROSS-MATCH
    PIROFSKY, B
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1959, 32 (04) : 350 - 356
  • [36] Can we transplant with a positive cross-match?
    Alamartine, E
    Acquart, S
    Absi, L
    Diab, N
    deFilippis, JP
    LePetit, JC
    Berthoux, F
    NEPHROLOGIE, 1997, 18 (05): : 175 - 180
  • [37] Value of a flow cytometry cross-match in the setting of a negative complement-dependent cytotoxicity cross-match in heart transplant recipients
    Keeshan, Britton C.
    O'Connor, Matthew J.
    Lin, Kimberly Y.
    Monos, Dimitrios
    Lind, Curt
    Mascio, Christopher E.
    Rame, Jesus Eduardo
    Spray, Thomas L.
    Shaddy, Robert E.
    Rossano, Joseph W.
    CLINICAL TRANSPLANTATION, 2017, 31 (10)
  • [38] A MICROCOMPUTER PROGRAM FOR CADAVER DONOR CROSS-MATCH
    LAZDA, VA
    BLAESING, ME
    MONLEY, CA
    JOHNSON, JS
    ZAWISLAK, DJ
    JONASSON, O
    HUMAN IMMUNOLOGY, 1985, 14 (02) : 144 - 145
  • [39] IS FLOW CYTOMETRY CROSS-MATCH AS SENSITIVE AS THE VIRTUAL CROSS-MATCH TO DETECT CLASS I ANTI-HLA ANTIBODIES? A COMPARATIVE STUDY
    Chabot, Valerie
    Humeau, Camille
    Achar, Franckie
    Boucharin, Valerie
    Tartarin, Beatrice
    Walencik, Alexandre
    Gautier, Anne Cesbron
    Buchler, Matthias
    Proust, Barbara
    HLA, 2019, 93 (05) : 310 - 311
  • [40] REMOTE CROSS-MATCH - A KEY TO CENTRALIZATION OF TRANSFUSION SERVICES
    HAHN, L
    CASCIOLA, T
    CORNELL, F
    GOLLING, F
    TRANSFUSION, 1993, 33 (09) : S99 - S99